Teratogenic Effects of Oral Hypoglycemic Agents

Washington, Ida M.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
• Type: First Independent Research Support & Transition (FIRST) Awards (R29)
• Project #: 5R29HD029443-03
• Application #: 2201863
• Study Section: Human Embryology and Development Subcommittee 1 (HED)
• Project Start: 1994-05-01
• Project End: 1999-04-30
• Budget Start: 1996-05-01
• Budget End: 1997-04-30
• Support Year: 3
• Fiscal Year: 1996

Institution

• Name: North Carolina State University Raleigh
• Department: Anatomy/Cell Biology
• Type: Schools of Veterinary Medicine
• City: Raleigh
• State: NC
• Country: United States
• Zip Code: 27695

Publications

Smoak, Ida W (2002) Tolbutamide alters glucose transport and metabolism in the embryonic mouse heart. Teratology 65:19-25

Smoak, I W; Branch, S (2000) Glut-1 expression and its response to hypoglycemia in the embryonic mouse heart. Anat Embryol (Berl) 201:327-33

Smoak, I W (1999) Cromakalim: embryonic effects and reduction of tolbutamide-induced dysmorphogenesis in vitro. Teratology 60:260-4

Smoak, I W; Emanuel, A N (1998) Tolbutamide: placental transfer, tissue distribution, and metabolic effects in murine embryos. Pharmacol Toxicol 82:203-8